✦ LIBER ✦

Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand

✍ Scribed by Chitraporn Karnasuta; Robert M. Paris; Josephine H. Cox; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Arthur E. Brown; Sanjay Gurunathan; James Tartaglia; William L. Heyward; John G. McNeil; Deborah L. Birx; Mark S. de Souza

Book ID: 116957685
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 176 KB
Volume: 23
Category: Article
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2004.10.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HLA class II restriction of HIV-1 clade-

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E

✍ Robert Paris; Sasitorn Bejrachandra; Prasert Thongcharoen; Sorachai Nitayaphan; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Corrigendum to “Lessons from IAVI-006, a

Corrigendum to “Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers” [Vaccine 26 (2008) 6671–6677]

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 91 KB